All 1 tracked stories fall under one category: market-trends. Evolent is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 6 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Seth Blackley
All 1 tracked stories fall under one category: market-trends. Evolent is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 6 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window. Seth Blackley appears in 1 tracked Healthcare story from February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Seth Blackley. Shared-story counts are live from our verified record — not editorial picks.
Evolent and Standard BioTools reported Q4 and full-year 2025 financial results, highlighting a sector-wide shift toward operational efficiency and consolidation. While Evolent scales its specialty care management platform, Standard BioTools is navigating the final stages of its SomaLogic integration amidst a complex life sciences market.